Skip to main content

Table 3 CKRT settings, vital signs, interventions

From: Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study

Variables

n = 269

Blood flow rate: QB, ml/min

106.0 ± 12.9

Continuous haemodiafiltration (CHDF)

115 / 269 (42.8%)

 Dialysate flow rate: QD, mL/kg/h

22.3 ± 13.4

 Filtration rate: QF, ml/kg/h

9.7 ± 4.3

Continuous haemodialysis (CHD)

154 /269 (57.2%)

 Dialysate flow rate: QD, mL/kg/h

18.3 ± 15.8

Fluid removal rate, ml/h

49.0 ± 112.4

Mean arterial pressure at the start of CKRT, mmHg

81.1 ± 19.6

Heart rate at the start of CKRT, bpm

94.3 ± 22.3

Respiratory rate at the start of CKRT, /min

21.1 ± 6.7

Intervention

 

Noradrenaline at the start of CKRT

132 (49.1%)

Vasopressin at the start of CKRT

45 (16.7%)

  1. Values are presented as means with standard deviations, otherwise specified
  2. CKRT denotes continuous kidney replacement therapy